Latest news with #PlanetMicroCapShowcase:VEGAS2025
Yahoo
23-04-2025
- Business
- Yahoo
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
BROOMFIELD, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ('Aclarion' or the 'Company') (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:30 PM ET. Brent Ness, Chief Executive Officer of Aclarion, will be presenting on the Company and recent value-driving initiatives. In conjunction with the event, Aclarion has published its updated investor presentation, which can be found on its website at About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as 'anticipates,' 'believes' and 'expects' or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contacts: Kirin M. SmithPCG Advisory, Media Contact: Jennie KimSPRIG Consultingjennie@ in to access your portfolio
Business Wire
22-04-2025
- Automotive
- Business Wire
Pioneer Power to Present at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
FORT LEE, N.J.--(BUSINESS WIRE)-- Pioneer Power Solutions, Inc. (Nasdaq: PPSI) ('Pioneer' or the 'Company'), a leader in the design, manufacture, service and integration of distributed energy resources, power generation equipment and mobile electric vehicle ('EV') charging solutions, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 9:00AM (Local Time - PDT). Nathan Mazurek, Chairman and CEO of Pioneer, will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub Date: Wednesday, April 23, 2025 Time: 9:00AM (Las Vegas, NV Local Time PDT) Webcast: If you would like to book 1x1 investor meetings with Pioneer Power, and to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please make sure you are registered here: REGISTER 1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV The Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub website is available here: HOME PAGE If you can't make the live presentation, all company presentations 'webcasts' will be available directly on the conference event platform on this link under the tab 'Agenda': AGENDA About Pioneer Power Solutions, Inc. Pioneer Power Solutions, Inc. is a leader in the design, manufacture, integration, refurbishment, service and distribution of electric power systems, distributed energy resources, power generation equipment and mobile electric charging solutions for applications in the utility, industrial and commercial markets. To learn more about Pioneer, please visit its website at e-Boost is Pioneer's portfolio of smart, mobile EV charging solutions. The Company has been aggressively marketing e-Boost to electric bus and truck manufacturers, fleet management companies, municipalities and EV infrastructure providers since its initial launch in November 2021. About Planet MicroCap Planet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space. If you would like to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please register here:
Yahoo
22-04-2025
- Business
- Yahoo
FitLife Brands to Present at Planet MicroCap Investor Conference
OMAHA, NE, April 22, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ('FitLife' or the 'Company') (Nasdaq: FTLF), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 9:30 AM (Local Time - PST). Dayton Judd, the Company's Chairman & CEO, and Ryan Hansen, the Company's Executive Vice President, will be hosting the presentation and answering questions at the conclusion. Investors can access the live presentation using the following information: Date: Wednesday, April 23, 2025 Time: 9:30 AM (Las Vegas, NV Local Time PST) Webcast: Following the live presentation, a recording will be available using the follow link: AGENDA About FitLife BrandsFitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through various retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at About Planet MicroCapPlanet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community that has cultivated an active and engaged audience that is interested in learning about and staying ahead of the curve in the MicroCap space. Contactinvestor@ CONTACT: investor@ in to access your portfolio
Yahoo
21-04-2025
- Business
- Yahoo
Telescope Innovations to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
Showcase is in partnership with MicroCapClub, and 1x1 meetings with Telescope COO are available on April 24, 2025 Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 2:00-2:30 PM (Local Time - PST). Chief Operating Officer, Dr. Jeffrey W. Sherman of Telescope Innovations Corp. will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClubDate: Wednesday, April 23, 2025Time: 2:00-2:30 PM (Las Vegas, NV Local Time PST)Webcast: Recent Company Highlights Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC™ Telescope Innovations Commences Trading on the Frankfurt Stock Exchange Telescope Innovations Founder and CTO, Professor Jason Hein, Honoured with 2025 R. U. Lemieux Award - Telescope Innovations Second Nobel Prize Won by Telescope Innovations Advisor - Telescope Innovations If you would like to book 1x1 investor meetings with Telescope Innovations, and to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please make sure you are registered here: REGISTER 1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV. If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the AGENDA tab. About Telescope Innovations Telescope Innovations is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability. About Planet MicroCap Planet MicroCap is a global multimedia financial news, publishing and events company for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space. If you would like to attend the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, please register here. Contact Name: Jeffrey W. Sherman, +1 443-454-7525Email: jeff@ To view the source version of this press release, please visit
Yahoo
21-04-2025
- Business
- Yahoo
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
Company to conduct 1x1 meetings on April 24, 2025 GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ('Shuttle Pharma' or the 'Company'), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time). Anatoly Dritschilo, M.D., Chairman of the Board of Directors and Chief Scientific Officer of Shuttle Pharma, will be hosting the presentation and answering questions at the conclusion. Dr. Dritschilo's presentation will focus on providing an overview and update on the Company's ongoing Phase 2 trial of Ropidoxuridine and RT for treatment of patients with glioblastoma as well as advancements being made in the Company's Shuttle Diagnostics subsidiary which aims to develop pretreatment diagnostic blood tests and imaging agents for prostate cancer patients. To access the live presentation, please use the following information: Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub Date: Wednesday, April 23, 2025 Time: 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) Location: Track 3 – Chablis at the Paris Hotel & Casino in Las Vegas, NV Webcast: If you would like to schedule a 1x1 meeting with management, please contact your Planet MicroCap representative or the Company's investor relations team at 1x1@ 1x1 meetings will be scheduled and conducted in person at the conference venue: Paris Hotel & Casino in Las Vegas, NV About Shuttle Pharmaceuticals Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). Our mission is to improve the lives of cancer patients by developing therapies that are designed to maximize the effectiveness of RT while limiting the side effects of radiation in cancer treatment. Although RT is a proven modality for treating cancers, by developing radiation sensitizers, we aim to increase cancer cure rates, prolong patient survival and improve quality of life when used as a primary treatment or in combination with surgery, chemotherapy and immunotherapy. For more information, please visit our website at Safe Harbor Statement Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of Shuttle Pharma's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 26, 2025, as well other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, Shuttle Pharmaceuticals specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Shuttle PharmaceuticalsAnatoly Dritschilo, and Chief Scientific Officer240-403-4212info@ Investor ContactsLytham Partners, LLCRobert Blum602-889-9700shph@
